Form D — Rhinal Therapeutics Inc.
0002080382-25-000001 · filed Aug 7, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $1,000,000
- Reported amount sold
- $20,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Rhinal Therapeutics Inc.
- CIK
- 2080382
- Entity
- Corporation
- Jurisdiction
- NEVADA
- Year incorporated
- 2023
- Address
- 732 S 6TH ST
LAS VEGAS, Nevada 89101 - Phone
- 7029816980
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Lawrence Fox · Executive OfficerLas Vegas, Nevada Find on LinkedIn ↗
-
Frank Puglisi · Executive OfficerLas Vegas, Nevada Find on LinkedIn ↗
-
Austin Panhans · Executive OfficerLas Vegas, Nevada Find on LinkedIn ↗
-
Robert Clayborough · Executive OfficerLas Vegas, Nevada Find on LinkedIn ↗
-
Mike George · DirectorLas Vegas, Nevada Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗